Taiwan FDA registration c9fb04adcef50de16a5792a2cd3139fc
VIDAS Anti-TG
TW: 威達獅甲狀腺球蛋白抗體試劑組
Taiwan·Risk Class 2·MD·BIOMERIEUX S.A.·Registered Aug 17, 2015 – Aug 17, 2025ExpiredRegistration details
- Analysis ID
- c9fb04adcef50de16a5792a2cd3139fc
- License Form
- Ministry of Health Medical Device Import No. 027555
- Customs Code
- DHA05602755506
Company information
- Manufacturer
- BIOMERIEUX S.A.
- Manufacturer Country
- France
- Authorized Representative
- Hong Kong Commercial Mérieux S.p.A. Taiwan Branch
Product details
- Intended Use
- This product is an automated quantitative assay used in the VIDAS system to detect thyroglobulin IgG autoantibodies in human serum or plasma by enzyme-linked fluorescence analysis (ELFA).
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C5870 Thyroid autoantibody immunoassay system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Aug 17, 2015
- Expiry Date
- Aug 17, 2025
About this record
Access comprehensive regulatory information for VIDAS Anti-TG in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c9fb04adcef50de16a5792a2cd3139fc and manufactured by BIOMERIEUX S.A.. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices